Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains an Intellectual Property High Court decision addressing the applicability of the abuse of right doctrine in a design invalidation action -
Sponsored by Tilleke & GibbinsLoc Xuan Le, Giang Hoang Bach, and Duc Anh Tran of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins, report on a rare challenge to a non-use cancellation
-
Sponsored by Bird & BirdMarta Koremba, Mateusz Żuk, and Michał Liszka of Bird & Bird report on a notable judgment concerning an infringement of the Prosecco geographical indication in the cosmetics sector
-
Sponsored by Saint Island International Patent & Law OfficesSumin Lai of Saint Island International Patent & Law Offices outlines how the decisions offer valuable insights into inventive step assessment in Taiwanese patent disputes
-
Sponsored by MaiwaldKerstin Wolff and Tobias Matschke of Maiwald Intellectual Property examine a landmark Unified Patent Court decision on second medical use claims and compare it with Germany’s established approach to ‘skinny label’ products
-
Sponsored by Spoor & FisherHerman Blignaut of Spoor & Fisher South Africa addresses whether the act extends to intellectual property rights and reassures brand owners that constitutional protection remains intact
